A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland. by Raven, Kathy E et al.
Raven, KE; Reuter, S; Reynolds, R; Brodrick, HJ; Russell, JE; Trk,
ME; Parkhill, J; Peacock, SJ (2016) A decade of genomic history for
healthcare-associated Enterococcus faecium in the United Kingdom
and Ireland. Genome research, 26 (10). pp. 1388-1396. ISSN 1088-
9051 DOI: https://doi.org/10.1101/gr.204024.116
Downloaded from: http://researchonline.lshtm.ac.uk/2901295/
DOI: 10.1101/gr.204024.116
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
A decade of genomic history for healthcare-associated
Enterococcus faecium in the United Kingdom and Ireland
Kathy E. Raven,1 Sandra Reuter,1,2 Rosy Reynolds,3,4 Hayley J. Brodrick,1 Julie E. Russell,5
M. Estée Török,1,6,7 Julian Parkhill,2 and Sharon J. Peacock1,2,7,8
1University of Cambridge, Department of Medicine, Addenbrooke’s Hospital, Cambridge CB2 0QQ, United Kingdom; 2The Wellcome
Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom; 3British Society
for Antimicrobial Chemotherapy, Birmingham B1 3NJ, United Kingdom; 4North Bristol NHS Trust, Southmead Hospital, Bristol,
BS10 5NB, United Kingdom; 5Culture Collections, Public Health England, Porton Down, Salisbury SP4 0JG, United Kingdom;
6Public Health England, Clinical Microbiology and Public Health Laboratory, Addenbrooke’s Hospital, Cambridge CB2 0QQ, United
Kingdom; 7Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom; 8London School
of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom
Vancomycin-resistant Enterococcus faecium (VREfm) is an important cause of healthcare-associated infections worldwide. We
undertook whole-genome sequencing (WGS) of 495 E. faecium bloodstream isolates from 2001–2011 in the United Kingdom
and Ireland (UK&I) and 11 E. faecium isolates from a reference collection. Comparison betweenWGS andmultilocus sequence
typing (MLST) identified major discrepancies for 17% of isolates, with multiple instances of the same sequence type (ST)
being located in genetically distant positions in the WGS tree. This confirms thatWGS is superior to MLST for evolutionary
analyses and is more accurate than current typing methods used during outbreak investigations. E. faecium has been catego-
rized as belonging to three clades (Clades A1, hospital-associated; A2, animal-associated; and B, community-associated).
Phylogenetic analysis of our isolates replicated the distinction between Clade A (97% of isolates) and Clade B but did
not support the subdivision of Clade A into Clade A1 and A2. Phylogeographic analyses revealed that Clade A had
been introduced multiple times into each hospital referral network or country, indicating frequent movement of E. faecium
between regions that rarely share hospital patients. Numerous genetic clusters contained highly related vanA-positive and
-negative E. faecium, which implies that control of vancomycin-resistant enterococci (VRE) in hospitals also requires consid-
eration of vancomycin-susceptible E. faecium. Our findings reveal the evolution and dissemination of hospital-associated
E. faecium in the UK&I and provide evidence for WGS as an instrument for infection control.
[Supplemental material is available for this article.]
Enterococcus faecium is a commensal of the gastrointestinal
tract (Endtz et al. 1997) and an important cause of healthcare-asso-
ciated infection, particularly in immunocompromised patients
(Montecalvo et al. 1996; Patel 2003). In 2014, enterococci were
the second most commonly isolated microorganism from ICU-ac-
quired bloodstream infections in Europe (European Centre for
Disease Prevention and Control 2015). In addition to carriage by
hospital patients (Endtz et al. 1997), E. faecium can also be shed
into the environment, where this can persist for extended periods
of time (Falk et al. 2000; Neely and Maley 2000). Transmission of
E. faecium from one patient to another through direct or indirect
spread underlies nosocomial infection, the prevention of which
depends on infection control interventions, including hand hy-
giene, environmental cleaning, and effective detection and con-
trol of outbreaks.
Bacterial typing is used to add evidence to infection control
epidemiology during outbreak investigations and to gain an un-
derstanding of the population structure of E. faecium. Multilocus
sequence typing (MLST) was described for E. faecium in 2002
(Homan et al. 2002), which assigns most clinical isolates world-
wide to a hospital-associated clonal complex (CC)17 (Willems
et al. 2005) based on eBURST. Hospital-associated strains are gen-
erally resistant to ampicillin (Willems et al. 2005) and quinolones
(Leavis et al. 2006) and are enriched in mobile elements, putative
virulence determinants, and resistance to antibiotics (Kim and
Marco 2014). eBURST clusters multilocus sequence types (STs)
into CCs based on identity of five of the seven MLST loci, but
this is less reliable when identifying genetic relatedness in highly
recombining species, including E. faecium (Turner et al. 2007).
More recently, it has been proposed that CC17 consists of two
distinct groups of STs based on Bayesian Analysis of Population
Structure (BAPS) analysis of MLST loci (BAPS groups 2-1 [contain-
ing ST78] and 3-3 [containing ST17 and ST18]) (Willems et al.
2012). BAPS 3-3 is associated with nosocomial isolates, while
BAPS 2-1 is associated with animal isolates andmay have a distinct
evolutionary history (Willems et al. 2012). The accuracy of MLST
has been evaluated using whole-genome sequencing (WGS) in
three previous studies. Howden et al. (2013) reported that five of
the seven MLST genes in E. faecium are under recombination and
identified two of 61 isolates with a discrepancy between WGS
data andMLST, a finding supported by van Hal et al. (2016), while
Pinholt et al. (2015) compared MLST to WGS data for 132 E. fae-
cium isolates from across Denmark and found good correlation.
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Four WGS-based studies of bacterial collections ranging in
size from 61 to 132 E. faecium isolates have been published to
date (Howden et al. 2013; Lebreton et al. 2013; Pinholt et al.
2015; van Hal et al. 2016). A study of a global collection of 73 E.
faecium from a range of sources reported the presence of two clades
(Clade A1 and B) associated with human clinical and commensal
isolates, respectively, together with a third genetically distinct
clade associated with animals (Clade A2) (Lebreton et al. 2013).
A close genetic relationship was established between vanB VRE
and vancomycin-susceptible enterococci (VSE) by a study con-
ducted in Australia (Howden et al. 2013). Additionally, WGS stud-
ies revealed transmission events within a hospital and suggested
that inter- and intra-regional spread of VRE clones may be occur-
ring (Howden et al. 2013; Pinholt et al. 2015; van Hal et al.
2016). Current knowledge gaps include studies that relate to
vanA VRE (the dominant transposon in the United States and
Europe), as well as comprehensive studies of E. faecium population
dynamics at national and international levels. Here, we use WGS
to define the population structure of E. faecium clinical isolates
in the United Kingdom and Ireland (UK&I) over a decade. These
data were further mined to evaluate the robustness of the current
MLST typing scheme and to describe the evolution of vancomycin
resistance encoded by vanA in this setting.
Results
Study design and bacterial isolates
We analyzed whole-genome sequence data for 506 E. faecium iso-
lates (250 vancomycin-resistant E. faecium [VREfm], 256 vanco-
mycin-susceptible E. faecium [VSEfm]) drawn from reference
(National Collection of Type Cultures [NCTC] n = 11) and national
(British Society for Antimicrobial Chemotherapy [BSAC] n = 495)
collections. NCTC isolates consisted of three VREfm and eight
VSEfm deposited between 1946 and 2007 and isolated before
1997. The BSAC collection consisted of isolates submitted to a bac-
teremia resistance surveillance program (www.bsacsurv.org) be-
tween 2001 and 2011 by 40 hospitals across the UK&I.
Comparison of MLST and WGS
We derived the ST from the WGS data. This resolved 53 STs for
501/506 isolates (Supplemental Fig. S1), 96% of which belonged
to CC17. The remaining five isolates could not be assigned to an
ST because the MLST locus pstS had been deleted, together with
five contiguous genes (three hypothetical proteins and two inser-
tion sequence [IS] elements) (Supplemental Fig. S2). A homolog of
pstS (Aus0004_02035) was identified in all study isolates, which
was contiguous with a pst operon (Supplemental Fig. S2). This sug-
gests that the MLST locus is a homolog of the actual housekeeping
gene. Interrogation of the Aus0004 genome with the MLST prim-
ers for pstS revealed that these bound specifically to the MLST pstS
locus and so only identified the homolog.
We then undertook a comparative phylogenetic analysis of
concatenated MLST loci versus WGS for a subset of 477 VREfm
and VSEfm isolates that resided in a closely related genetic cluster
(Clade A; see below). This revealed numerous discrepancies be-
tween the two methods with a conservative estimate of 80/477
(16.7%) isolates lacking congruence and with dispersal of isolates
belonging to the same ST throughout the WGS tree (Fig. 1). Four
MLST loci (atpA, gyd, pstS, ddl) were located in recombination hot-
spots and contributed to 78/80 of these discrepancies. In contrast,
the remaining three MLST loci showed very limited diversity.
Despite the size of the collection, we identified just three, two,
and two alleles, respectively, for adk, gdh, and purK. Furthermore,
a single allele accounted for 99.2%, 99.8%, and 93.7% of the 477
isolates, respectively, demonstrating that these three loci contrib-
uted very little to differentiation between isolates.We investigated
the performance of BAPS, which has been proposed as a replace-
ment for clustering byMLST CC. Six out of the 13 BAPs groups de-
scribed by Willems et al. (2012) were identified based on 32 STs
(473/506 isolates) in our collection, with BAPS groups 3-3 (62%
of isolates) and 2-1 (31%) being the most common (Supplemental
Fig. S1). Annotation of theWGS treewith BAPS groups showed two
distinct clusters predominantly containing BAPS 3-3 and 2-1, re-
spectively, but multiple discrepancies between BAPS and WGS
were also observed.
UK&I E. faecium genomes in a global genetic context
We combinedWGS data for the 506 study isolates with WGS data
for 73 isolates described in a study by Lebreton et al. (2013), in
which a clade structurewas identified consisting of Clades A1 (hos-
pital-associated), A2 (animal-associated), and B (community-asso-
ciated). The comparison was based on genes conserved across the
two collections (n = 1288), fromwhich single-nucleotide polymor-
phisms (SNPs) were identified and used to construct a maximum
likelihood tree. This confirmed previous observations that the
E. faecium population splits into two major lineages (Clades A
and B) but did not support the subdivision of Clade A into
Clades A1 and A2 (Fig. 2). The Lebreton Clade A2 isolates were
basal (ancestral) to Clade A1, and the phylogeny was consistent
with a rapid clonal expansion of Clade A from a single progenitor
(Fig. 2). We sought a methodological explanation for this differ-
ence. In our study we defined core genes as being present in 99%
of isolates and Lebreton et al. (2013) used a definition of 100%
of isolates, but a reanalysis based on 100% showed that the
phylogeny shown in Figure 2 was replicated (Supplemental Fig.
S3). Furthermore, it was possible to accurately reproduce the phy-
logeny created by Lebreton et al. (2013) for the 73 isolates alone
(Supplemental Fig. S3). This indicates that our findings relate to
the isolate collection (including its larger numerical size) as op-
posed to differences in analysis.
The majority (97%) of the BSAC collection resided in the
clonal expansion of Clade A, together with all three NCTC
VREfm isolates, including two from the first clinical case reports
of vancomycin-resistant E. faecium in 1988 (Uttley et al. 1988).
Nine study isolates from geographically dispersed locations
(London n = 2, East of England n = 1, West Midlands n = 1, South-
West n = 1, Northern Ireland n = 1, Ireland n = 1, Scotland n = 1,
NCTC n = 1) resided in Clade B. Overall, the clonal expansion of
Clade A had considerably lower genetic diversity (median 2174
SNPs, range 0–5701 SNPs, interquartile range (IQR) 1538–2772
SNPs) than either Clade B (median 11,673 SNPs, range 2957–
18,135, IQR 8289–14,627 SNPs) or the isolates that were basal to
Clade A (median 6833 SNPs, range 20–14,206 SNPS, IQR 4682–
8098 SNPs).
Phylogeography of E. faecium in the UK&I
Our sampling strategy provided the opportunity to describe the
phylogeny of E. faecium over time and place in the UK&I. A phy-
logenetic tree based on 8808 SNPs in the core genome of the
Aus0004 reference and 477 study isolates contained in the clonal
expansion of Clade A was analyzed by hospital referral network
for England (Donker et al. 2012), and by country for Wales,
Genome sequencing of E. faecium
Genome Research 1389
www.genome.org
 Cold Spring Harbor Laboratory Press on January 29, 2018 - Published by genome.cshlp.orgDownloaded from 
Scotland, Northern Ireland, and Ireland (Fig. 3). We found wide-
spread dissemination of Clade A and a pattern consistent with
multiple introductions into each referral network or country.
Superimposed on this dispersed pattern were small clusters with-
in the referral networks and countries, which are likely to repre-
sent localized transmission and clonal expansion. We also
identified two clusters that were geographically restricted to
Ireland/Northern Ireland (17 isolates from 2007–2011 and 18 iso-
lates from 2004–2010). Evidence for connectivity and transmis-
sion between different hospitals both within a referral network/
country and in different referral networks/countries was identi-
fied, including nine isolate pairs from different hospitals in the
same referral network/country and eight isolate pairs from dif-
ferent hospitals in different referral networks/countries, each
pairing being within zero to six core genome SNPs of each other.
Analysis by individual hospitals replicated the findings for refer-
ral networks, with dispersal of isolates throughout the tree
combined with clusters of isolates. Isolates from each year of
the study were distributed throughout the tree, although one
subpopulation appeared to have emerged after 2005 and consist-
ed of 126/131 isolates originating between 2006 and 2011
(Supplemental Fig. S4).
Genetic analysis of vancomycin resistance and virulence
We then analyzed the genetic basis of vancomycin resistance in
250 VREfm isolates. The majority (215/250; 86%) carried vanA,
with the remainder carrying vanB (n = 25) or both genes (n = 10).
All but one VREfm belonged to the clonal expansion of Clade
A. One Clade B isolate was vanA-positive, demonstrating that van-
comycin resistance was not restricted to the hospital-associated
lineage. Annotation of the tree with vanA and vanB showed a close
relationship between VREfm and VSEfm (Fig. 4A). Therewas also a
striking difference in distribution of the two elements, with vanA
distributed throughout the tree and vanB predominantly (36/44
isolates) located in four genetic clusters (Fig. 4A). Mapping se-
quence data to reference transposons revealed multiple small-
and large-scale variations in genetic content in the vanA transpo-
son, but limited genetic variation in the vanB transposon (zero
to five SNPs difference within each cluster) (Supplemental Fig.
S5). BLAST analysis of the transposon insertion sites revealed
that vanA was predominantly located on plasmids (161 of the
162 that could be identified: pLG1 [n = 80], pIP816 [n = 45],
or comparable matches to pLG1, pF856, p5753cA, and pS177
[n = 36]), while 42/44 vanB transposons were inserted into the
Figure 1. Concordance betweenMLST andWGS data. (A, left) Tanglegram linking isolates in phylogenetic trees based onWGS and concatenatedMLST
loci. A different color is used to represent each ST present inmore than one position in theWGS tree. Bars to the right show the STs indicated on the tree, the
genetic basis for discrepancies betweenMLST andWGS (recombination = purple; point mutation = orange), and BAPS groups (BAPS 2-1 = purple, BAPS 2-
3 = pink, BAPS 3-1 = green, BAPS 3-3 = yellow, unknown =white), with the positions on these bars relating to the position of the isolate on theWGS tree. (B)
Recombination across the genome. Red indicates a recombination event found inmore than one isolate; blue, a recombination event unique to that isolate.
MLST genes and reference sequence are indicated at the top.
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chromosome. Within each cluster, the vanB transposons were in-
serted at identical sites in the chromosome, suggesting acquisition
followed by clonal expansion. These results indicate that vanA has
been repeatedly acquired and lost in the UK&I collection and that
vanB has been acquired a limited number of times and retained.
Having observed the mobility of vanA across the bacterial
population,weundertook an analysis of vanAwithin individual re-
ferral networks (England) and countries. VREfm clusters predomi-
nantly harbored identical vanA transposons (Fig. 4B), indicating a
single acquisition and subsequent clonal expansion. One transpo-
son was found exclusively in Ireland (21/21), and a second pre-
dominantly (26/29) in the East of England (n = 19) and London
(n = 7). These two transposons were located in multiple distinct
positions on the phylogenetic tree (seven and five positions, re-
spectively), suggesting that they had been acquired multiple times
(Fig. 4C).
Eleven E. faecium isolates that were phenotypically suscepti-
ble to vancomycin also carried vanA (n = 1) or vanB (n = 10). The
ten vanB-positive VSEfm isolates resided in a single cluster span-
ning 5 yr and lacked the vanRB and vanSB regulatory genes, which
explains the discrepancy between the phenotype and genotype.
A possible explanation for the retention of the vanB transposon
in the absence of a selective advantage relating to vancomycin re-
sistance is the presence of a secondary fitness advantage arising
from other genes carried by the transposon. To investigate this,
we analyzed the pan-genome of the 506 isolates to identify genes
thatwere unique to vanB-positive isolates. Twenty-nine geneswere
identified, including a bacteriocin, integrase, and excisionase
(Supplemental Table S1). The excisionase suggests that these trans-
posons retained the ability to excise from the genome, while the
advantage associated with a bacteriocin may explain its persis-
tence. Of note, the single vanB isolate cultured prior to 1997 lacked
this bacteriocin.
Finally, we evaluated whether Clades A and B varied in their
composition of putative virulence determinants. A comparison of
eight E. faecium virulence genes from the Virulence Factor
Database (VFDB) identified four virulence factors (ebpA, esp, hyl,
scm) that were present in ≥50% of Clade A isolates but were ab-
sent from Clade B (Supplemental Fig. S6), one of which (esp) was
only identified in the clonal expansion of Clade A (Supplemental
Fig. S6).
Discussion
MLST has been used for over a decade to describe the population
structure of E. faecium and remains the cornerstone for defining
E. faecium populations. A striking finding of this study was that
the currently used MLST scheme is not robust. Our analyses re-
vealed considerable discrepancy between WGS and MLST and
showed that this had resulted from recombination. This contrasts
Figure 2. Population structure of E. faecium. Maximum likelihood tree based on SNPs in the 1288 genes core to the 506 isolates from this study and 73
isolates reported by Lebreton et al. (2013). Pink branches indicate Clade A; blue branches, Clade B. Inner incomplete red ring denotes the clonal expansion
of Clade A. Middle ring shows the isolate source (yellow, animal; purple, clinical; blue, nonhospital; black, hospital-associated feces/surveillance/outbreak/
unknown; green, other; white, unknown). Outer ring shows isolates from Lebreton et al. (2013) colored by the clade towhich theywere originally assigned
(pink, Clade A1; brown, Clade A2; blue, Clade B; black, hybrid Clade A1/B). Scale bar, 9593 SNPs.
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with the study by Pinholt et al. (2015), which identified good cor-
relation between WGS and MLST of 132 E. faecium isolates. While
discrepancies have been reported previously (Howden et al. 2013;
van Hal et al. 2016), our large and comprehensive study extends
current knowledge of the problem. We also identified five isolates
for which one of the MLST genes had been excised; these bacteria
could survive because the gene used in the MLST scheme is a ho-
molog of the phosphate binding protein housekeeping gene.
Additionally, we identified discrepancies between WGS and the
BAPS groups described by Willems et al. (2012), likely due to the
fact that these groupings are based on concatenated MLST genes.
The evidence base from this and other studies begins to build
the case of need to replace E. faecium MLST with WGS, which
over time will become increasingly feasible beyond the research
setting.
By using WGS, we identified two distinct lineages within E.
faecium that were consistent with the previously described
Clades A and B (Galloway-Peña et al. 2012; Palmer et al. 2012).
However, we found no evidence for the split of Clade A into the
two discrete subclades (Clades A1 and A2) proposed previously
(Lebreton et al. 2013). This difference could be due to the larger
collection of isolates used here or may be a feature of the UK&I
population. The majority of clinical isolates belonged to a clonal
expansion of Clade A, which appears to have emerged once from
a progenitor lineage associated with animals. These data provide
new insights into the emergence and evolution of the hospital-as-
sociated lineages of E. faecium.
In this study, the clade described previously as community-
associated (Clade B) containedmore clinical isolates than commu-
nity isolates (n = 15 and n = 8, respectively). This may be expected
since the study collection contained predominantly hospital-asso-
ciated bacteremia isolates. However, similar numbers of hospital
and community isolates were identified in Clade B in the study
by Lebreton et al. (2013) (n = 7 and n = 8, respectively), indicating
that there is insufficient evidence to describe this clade as commu-
nity-associated. We propose that the association between clades
and origin (hospital/community) be reframed, a process that will
gain traction from large-scale national and international studies.
This may be aided by a change in nomenclature to Clade 1,
Clade 2, etc., as existing and new lineages are identified.
The national distribution of E. faecium revealed by WGS in
our study indicates that clones frequently move between health-
care networks thatmore rarely share hospital patients. This finding
is supported by studies based on WGS from Denmark (Pinholt
et al. 2015) and Australia (Howden et al. 2013), which showed
genetically similar strains in different geographical regions, sug-
gesting this phenomenon is not restricted to the United
Kingdom. Since transfer of patients between different hospitals
may not fully explain the widespread dissemination, it may be
the case that hospital-associated lineages are also carried in the
community. Individuals can carry VRE for weeks to years after hos-
pital discharge (Park et al. 2011; Karki et al. 2013; Sohn et al. 2013),
and VRE can survive on environmental surfaces for at least
3 mo (Neely and Maley 2000), making transmission within the
Figure 3. Geographic distribution of E. faecium lineages across the UK&I. (A) Maximum likelihood tree based on SNPs in the core genome for national
isolates belonging to the clonal expansion of Clade A. Colors shown in the colored circle represent the referral network or country where the isolates were
cultured. Scale bar, 90 SNPs. (B) Map of regions and referral networks described previously (Donker et al. 2012). Centers that submitted samples to the
BSAC between 2001 and 2011 are represented by gray dots. Reproduced from Reuter et al. (2016).
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community a plausible possibility. Hospital-associated E. faecium
has largely been considered to be restricted to the hospital setting.
If factors outside of the hospital are involved, this would have im-
portant implications for infection prevention and control.
We showed that E. faecium isolates carrying vanA are geneti-
cally indistinguishable from VSE isolates at the core genome level,
which is consistent with findings fromAustralia for vanB (Howden
et al. 2013). This has important implications for infection control,
since VSE isolates need to be considered in infection control initia-
tives targeting VRE, a suggestion also proposed by Howden et al.
(2013) based on vanB-positive E. faecium. The findings in this study
provide important additional insights over current knowledge by
demonstrating that the dynamics of the vanA- and vanB-resistance
determinants differ. This may relate to the predominant presence
of vanA on plasmids compared with the integration and stable
carriage of vanB in the chromosome together with a putative sec-
ondary fitness benefit provided by a bacteriocin associated with
vanB. We also identified a vanA-positive isolate in Clade B, demon-
strating that vancomycin resistance is not restricted to the hospi-
tal-associated lineage. While only a single case, this is important
since the ability of vancomycin resistance to be acquired by other
lineages has potentially serious implications for the future control
of VRE.
Finally, we identified two vanA transposons with a higher
prevalence in the East of England and in Ireland respectively, sug-
gesting local circulation or a local source for vanA. Local circulation
of Tn1546 at the hospital level has been described (Kawalec et al.
2000, 2007; Naas et al. 2005; Lee et al. 2012), and geographical seg-
regation of Tn1546 has been reported by Schouten et al. (2001),
who categorizedTn1546 into two lineages dominating in different
countries. Investigation into the dominant source(s) of vanA will
be important, since it is repeatedly acquired by different lineages
and may represent a target for infection control.
Methods
Isolates and antimicrobial susceptibility testing
The study was approved by the National Research Ethics Service
(ref: 12/EE/0439) and the CUH Research and Development
Figure 4. Vancomycin resistance in E. faecium from the UK&I. (A) Relationship between VREfm and VSEfm. Maximum likelihood tree of 477 study iso-
lates belonging to the clonal expansion of Clade A. Colored circle denotes presence of vanA (yellow), vanB (purple), vanA and vanB (green), or none
(vancomycin susceptible, white). Scale bar, 90 SNPs. (B) Acquisition of vancomycin resistance within hospitals. Maximum likelihood trees of two clusters
labeled by year of isolation and colored by hospital: genes present (black) or absent (white) from the vanA transposon. Scale bar, 27 SNPs. (C ) Locally
prevalent transposons. Maximum likelihood tree of national isolates belonging to the clonal expansion of Clade A. Colored circles denote isolates carrying
transposons overrepresented in Ireland (inner) or the East of England (outer) colored by referral network or country (green, Ireland; blue, East of England;
brown, London; navy, Yorkshire; pink, West Midlands; red, North East). (Bottom) Genetic content of the vanA transposon for both transposon types. Scale
bar, 90 SNPs.
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(R&D) department. Five hundred and fifteen isolates were ob-
tained from NCTC (n = 11) and the BSAC (n = 504). The BSAC col-
lection consisted of isolates submitted to a bacteremia resistance
surveillance program (www.bsacsurv.org) between 2001 and
2011 from 40 hospital microbiology laboratories across UK&I.
Thesewere assigned to referral networks, defined as clusters of hos-
pitals that are more likely to exchange patients within the cluster
than with hospitals outside of that cluster (Donker et al. 2012).
All VREfm isolates in the BSAC collection were obtained and se-
quenced (n = 256). A subset of 248 VSEfm were selected from
the BSAC collection, matched where possible with a VRE isolate
from the same hospital and year (n = 121), or hospital (n = 88).
Nine VREfm isolates were subsequently excluded from further
analysis for technical reasons, giving an overall total of 506 ge-
nomes taken forward into the analysis (for details, see Supplemen-
tal Table S2). The number of isolates by year of isolation for the
BSAC collection is shown in Supplemental Figure S6. Antimicrobi-
al-susceptibility testing was performed using the Vitek2 instru-
ment with a P607 card (Biomerieux) for isolates provided by
NCTC and using the agar dilutionmethod for the BSAC collection
(Andrews 2001).
Whole-genome sequencing and data analysis
DNA extraction, sequencing, and assembly of reads were per-
formed as previously described (Raven et al. 2016). Sequencing
was performed on an Illumina HiSeq2000. Details of reads, depth
of coverage, and N50 are provided in Supplemental Table S3. All
isolates had greater than 74× coverage overall, andhad aminimum
of 73% of the genomewith 50× coverage or higher. Genomes were
assembled using Velvet (Zerbino and Birney 2008) with the im-
provements described previously (Page et al. 2016a). STswere iden-
tified from the sequence data using the MLST database (pubmlst.
org/efaecium) and an in-house script (Supplemental File S1;
https://github.com/sanger-pathogens/mlst_check). BAPS groups
were defined based on the concatenated MLST genes, as described
byWillems et al. (2012). STs identified in this study were cross-ref-
erenced with those described by Willems et al. (2012), and BAPS
groups were assigned where there was overlap.
Study genomes were contextualized against a global collec-
tion. Sequence data for 73 E. faecium isolates reported previously
(Lebreton et al. 2013) were downloaded from the ENA, combined
with the 506 study genomes, and the 579 genomeswere annotated
using Prokka. The pangenome was estimated using Roary (Page
et al. 2015), and an alignment was created of all core genes that
were present in 99% of isolates. SNPs in the core genes were ex-
tracted (Page et al. 2016b) and used to construct a maximum like-
lihood tree using RAxMLwith 100 bootstraps and amidpoint root.
Study genomes were related to the previous clade classification
(Clades A1, A2, and B) by Lebreton et al. (2013). Genetic diversity
was defined within and between the two clades based on pairwise
SNP differences and excluded a single outlying isolate that resided
between Clades A and B.
Four hundred and seventy-nine BSAC isolate genomes clus-
tered within a single clonal expansion of Clade A. Sequence reads
for 477/479 genomes were mapped to the E. faecium reference
strain Aus0004 (ENA accession no. CP005531) using SMALT.
Two isolates were excluded because identification of recombina-
tion events failed. Genetic regions were classed as mobile genetic
elements if the annotation predicted phage-, plasmid-, IS-, or
transposon-related genes or if PHAST (Zhou et al. 2011) identified
a putative prophage (phast.wishartlab.com). These regions plus re-
combination identified using Gubbins (Croucher et al. 2014) were
removed from the genomes mapped to the reference genome to
create a “core” genome (Supplemental File S2; https://github.
com/sanger-pathogens/remove_blocks_from_aln). SNPs in this
core genomewere used to createmaximum likelihood phylogenies
using RAxMLwith 100 bootstraps and a midpoint root. Trees were
visualized using FigTree and iTOL (Letunic and Bork 2007, 2011).
A phylogenetic comparison was made between MLST and
WGS. MLST loci were concatenated and aligned, and a RAxML
tree was constructed with 100 bootstraps and a midpoint root.
This was compared to the maximum likelihood tree based on
SNPs in the core genome using Dendroscope (Huson et al. 2007;
Huson and Scornavacca 2012). A conservative estimate of the
number of discrepancies between WGS and MLST trees was
made based on the following assumptions. The largest cluster for
each STwas assumed to be the correct assignment, as were STs con-
taining a single isolate. The exceptions were ST17, ST18, and
ST203, which were each distributed throughout a single branch
of the tree but intermixed with other STs. This distribution sug-
gested that these could be the basal ST for the branch, and there-
fore, all of the isolates on the branch with that ST were assumed
to be in the correct position. A discrepancy was defined when
one ormore isolates resided on a branch of the tree that was genet-
ically distinct from the presumed correct position. The genetic
basis for discrepancies were ascribed to recombination ormutation
through a manual analysis of the sequence data. A mutation in an
MLST locus was defined when there was a single SNP in the locus
compared with the sequence of the locus in surrounding isolates.
A recombination event over an MLST locus was suspected when
there was more than one SNP in the locus compared with the se-
quence of the locus in surrounding isolates. Suspected recombina-
tion events were then verified through analysis of recombination
regions across the entire genome, identified using Gubbins
(Croucher et al. 2014). Recombination events over the MLST loci
were mapped against the phylogeny to determine whether a re-
combination event had occurred over one or more of the relevant
MLST loci in the branch leading to the discrepant ST(s). Homologs
of the MLST locus pstSwere identified by comparing the E. faecalis
pstS1 (the basis for the E. faeciumMLST scheme) and the E. faecium
Aus0004 genome using BLASTN.
Vancomycin resistance
The presence of vanA and vanB were established by in silico PCR
using published primers (Dutka-Malen et al. 1995; Depardieu
et al. 2004). Sequence reads were mapped to a relevant reference
using SMALT (Tn1546 [ENA accession no. M97297] from E. fae-
cium strain BM4147 for vanA, and Aus0004 reference genome
[2835430–2869240 bp] for vanB). Regions of sequence upstream
of and downstream from the vanA and vanB transposons were
identified as previously described (Howden et al. 2013). Insertion
sites were identified as follows. vanB, regions of up to 10,000 bp
were identified upstream of and downstream from the vanB trans-
poson and compared using BLASTN; vanA, the last 734 bp (vanZ
plus inverted repeat) of Tn1546 and the adjacent sequence up to
5000 bp for a single representative of each unique 5000 bp was
compared with a local database of all 506 assemblies using
WebACT. Variations in the vanA and vanB transposons were deter-
mined by identifying SNPs compared to the reference and by
comparing the regions of the reference transposon that were pre-
sent/absent.
Virulence genes
Putative E. faecium virulence genes in the 506 study genomes were
identified from the VFDB (http://www.mgc.ac.cn/VFs/). Gene
presence was detected by in silico PCR using previously published
primers, as follows: acm (Nallapareddy et al. 2003), ebpA (Sillanpää
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et al. 2010), ecbA (Soheili et al. 2014), esp (Vankerckhoven et al.
2004), scm (Soheili et al. 2014), sgrA (Soheili et al. 2014), hyl
(Vankerckhoven et al. 2004), and efa (Eaton and Gasson 2001).
Data access
Sequence data from this study have been submitted to the
European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena)
under the accession numbers listed in Supplemental Table S2.
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